News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

01

2025

-

12

Exploring the Linuo Pharmaceutical Computing Center: Unlocking the “Smart Brain” of the Intelligent Factory

Classification:

行业新闻

Corporate News


Remember the first two episodes. Linuo Pharmaceutical Injection Project “Cloud Factory Tour” Huh? We’ve taken everyone on a tour of the No. 1 Digital Intelligence Factory’s injection-production line, which boasts millimeter-level precision, and we’ve also checked in at the smart laboratory capable of detecting impurities at the trillionth-level. If we were to describe the production line... “Smart Manufacturing Limbs,” the laboratory is “The Eye of Quality”—the one that’s about to be unveiled today. — The Linuo Pharmaceutical Injection Dosage Calculation Center is the backbone supporting the entire digital and intelligent manufacturing system. “Intelligent Hub.”

This is nestled in the core area of the project site. The “Data Brain” is leveraging cutting-edge hardware and intelligent algorithms to integrate data across the entire value chain—from production and inspection to R&D and marketing. “Live” Get up. Now, join us as we step into this... “Computing Power Fortress”!

It’s not just the server room—it’s the “data heart” of the factory.

As soon as you step into the computing power center, the first thing that catches your eye isn't the roaring machinery—it's the large CNC display screen covering an entire wall. On the screen, device operating statuses, environmental parameters, quality indicators, and energy consumption data are flashing in real time... It’s as if the “vital signs” of the entire factory are laid out right before your eyes.

“This isn’t just a place for data storage and computation—it’s the decision-making brain of the entire Digital Intelligence Factory No. 1,” explained a staff member. “We collect massive amounts of data from various links—including the production line, laboratories, and warehousing and logistics—and after cleaning, integrating, and modeling this data, we ultimately develop an intelligent decision-support system that can optimize production.”

Interconnect multiple regions to build a “distributed computing power network.”

This computing power center does not exist in isolation. Centered on Jinan, it has established a distributed computing network that connects to Beijing, Shanghe, Yinan, Hainan, and other regions, enabling off-site data backups and collaborative computing. This means that even if one node experiences an anomaly, the system can still operate stably, ensuring uninterrupted production and preventing data loss.

“What we’re building is a secure, efficient, and scalable computing platform specifically tailored for the pharmaceutical industry,” the technician added. “In the future, we’ll also integrate more external data sources—including data from R&D partners, market feedback, and supply-chain dynamics—to truly achieve data-driven operations across the entire value chain, from R&D all the way to sales.”

Digital Twin: “Rehearsing” Reality in the Virtual World

One of the most remarkable applications of computing power centers is the digital twin system. By leveraging high-precision modeling and real-time data mapping, the system constructs a “digital factory” in the virtual world that perfectly mirrors the physical factory.

“We can simulate equipment operation, optimize process parameters, predict failure risks, and even conduct ‘virtual pilot production’ within the digital twin system,” the engineer explained. “This significantly reduces both the cost and time required for debugging in actual production, making our production lines smarter and more agile.”

From “manufacturing” to “intelligent manufacturing,” computing power is the driving force behind the shift.

If the production line is the “limbs” and the laboratory is the “senses,” then the computing power center is the “brain” of this smart factory. It’s not just an integration of technologies—it’s a deep fusion of business logic and data intelligence. It’s precisely on this computing power foundation that Linuo Pharmaceutical can achieve:

Production process of Real-time optimization

Quality risk's Early warning

Energy consumption's Precise control

End-to-end Transparent management

The Linuo Pharmaceutical Computing Center leverages computing power to empower manufacturing and uses data to anticipate the future, truly bringing the concept of “smart factories” from theory into reality. We look forward to exchanging ideas and learning from our upstream and downstream partners, fostering deep collaboration across R&D, production, and marketing, and working together for mutual development and win-win outcomes!

 

Product / Sales Collaboration: Sun Jinyu 15827087815

 

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

2026-05-13

On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

2026-05-07

On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.

Great news! First prize!

Great news! First prize!

2026-05-07

Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.